Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FTC To Testify On Generic Reform; Agency Report May Be “Months” Away

Executive Summary

Patent licensing deals that relate exclusively to listing in FDA's "Orange Book" will attract antitrust scrutiny, FTC Office of Policy Planning Director Ted Cruz said

You may also be interested in...



Authorized Generics Noose Tightens With “Best Price” Proposal, FTC Study

The Federal Trade Commission's decision to study the practice of authorized generics could become moot if the marketing of such products by brand companies becomes financially unattractive due to a potential change in Medicaid "best price" reporting requirements

Authorized Generics Noose Tightens With “Best Price” Proposal, FTC Study

The Federal Trade Commission's decision to study the practice of authorized generics could become moot if the marketing of such products by brand companies becomes financially unattractive due to a potential change in Medicaid "best price" reporting requirements

Rx Pricing Attacks Fail In Key House Races; Medicare Rx Vote Protects GOP

The House leadership is unlikely to change its approach to Medicare prescription drug coverage and pharmaceutical pricing following the Republican victories in the mid-term elections Nov. 5

Related Content

UsernamePublicRestriction

Register

PS039703

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel